Virtual Event | Drug Patents and Evidence-Based Policymaking in Patent Law

April 2022

Past Event

Virtual Event | Drug Patents and Evidence-Based Policymaking in Patent Law

Past Event

Online Only

April 15, 2022

Glass medicine bottles on a production line. (Getty Images)

April 2022

Past Event

1201 Pennsylvania Avenue, N.W., Suite 400
Washington, DC 20004

Speakers:

David Kappos

Partner, Cravath, Swaine & Moore LLP, Former Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office

Erika Lietzan

William H. Pittman Professor of Law & Timothy J. Heinsz Professor of Law, University of Missouri School of Law

Adam Mossoff

Chair, Forum for Intellectual Property, and Senior Fellow, Hudson Institute, and Professor of Law, Antonin Scalia Law School, George Mason University

This event will premiere on this page at 10:00 a.m. EDT, Friday, April 15. Register for the event here

Join Hudson Institute Senior Fellow Urška Petrovčič and expert panelists David Kappos, Erika Lietzan, and Senior Fellow Adam Mossoff for a discussion on the role of drug patents as a driver of innovation in healthcare and the importance of evidence-based policymaking in patent law.

Congress and federal agencies have been holding hearings, issuing reports, and considering various policy measures on whether drug patents raise prices in healthcare. These legislative and policy efforts have been driven by reports published by I-MAK of massively high numbers of patents on specific drugs. Yet as a recent Hudson Institute policy memo by Adam Mossoff explains, I-MAK’s patent numbers are unreliable and its private database is unverifiable. Please join our expert panel for a discussion on the policy debate over drug patents and the importance of evidence-based policymaking by Congress and agencies.

February 2026

In-Person Event | Invite Only

Assistant Secretary of State Christopher Yeaw on the End of the New START Treaty

Featured Speakers:

Christopher Yeaw

Rebeccah L. Heinrichs

A Russian Yars intercontinental ballistic missile launcher in Moscow on May 9, 2025. (Getty Images)

February 2026

In-Person Event | Invite Only

Assistant Secretary of State Christopher Yeaw on the End of the New START Treaty

Join Assistant Secretary of State for Arms Control and Nonproliferation Dr. Christopher Yeaw for a discussion on strategic deterrence.

Featured Speakers:

Christopher Yeaw

Rebeccah L. Heinrichs

Learn More

February 2026

In-Person Event | Hudson Institute

The Economic Case for the US-Israel Partnership with Minister of Economic Affairs Noach Hacker

Featured Speaker:

Noach Hacker

Moderator:

Michael Doran

February 2026

In-Person Event | Hudson Institute

The Economic Case for the US-Israel Partnership with Minister of Economic Affairs Noach Hacker

Featured Speaker:

Noach Hacker

Moderator:

Michael Doran

Learn More

February 2026

Past Event

Postponed | A Strategic Response to Sino-Russian Cooperation: Perspectives from Europe and the Indo-Pacific

Featured Speakers:

Nishank Motwani

Patrick M. Cronin

Justyna Szczudlik

Moderator:

Masashi Murano

February 2026

Past Event

Postponed | A Strategic Response to Sino-Russian Cooperation: Perspectives from Europe and the Indo-Pacific

Featured Speakers:

Nishank Motwani

Patrick M. Cronin

Justyna Szczudlik

Moderator:

Masashi Murano

Learn More

February 2026

Past Event

Gen. Pierre Schill on France’s Strategic Vision and Adapting Land Forces for High-Intensity Conflict

Featured Speakers:

General Pierre Schill

Rebeccah L. Heinrichs

February 2026

Past Event

Gen. Pierre Schill on France’s Strategic Vision and Adapting Land Forces for High-Intensity Conflict

Hudson welcomes French Army Chief of Staff General Pierre Schill, one of Europe’s most senior military leaders, for a discussion on the evolving strategic environment and the French Army’s transformation in a rapidly changing world.